[Retracted] The RPL4P4 Pseudogene Is a Prognostic Biomarker and Is Associated with Immune Infiltration in Glioma

Figure 3

Analysis of the prognostic value of RPL4P4 in different glioma subgroups. (a–h) Analysis of the prognostic value of RPL4P4 in different subgroups.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)